Allos Therapeutics Inc (ALTH)

Cancer has affected millions of people around the world in one way or another. Allos is in the business of trying to prevent those numbers from growing by creating drugs and therapies to combat various types of cancer.

Show Chart

Events

  • August 42012
    Allos Therapeutics, Inc. expected to report Q2 2012 results on August 4, 2012. This event was calculated by Capital IQ (Created on May 4, 2012).
  • March 42013
    Allos Therapeutics, Inc. expected to report Fiscal Year 2012 results on March 4, 2013. This event was calculated by Capital IQ (Created on March 8, 2012).

Members who own this company also own

the fun, safe & free way to learn the stock market Free! Sign up now! or log in

Current price per share

Today's gain: $0.00 (0.00%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon

Sign up or Sign in or continue to Explore We Seed